ARROWHEAD PHARMACEUTICALS, INC. Operating Lease Right-of-Use Assets
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Operating Lease Right-of-Use Assets of $55.67 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-04
- 2026-06-30: Operating Lease, Right-of-Use Asset $55.67M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $42.79M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $43.36M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $43.89M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $55.67M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $42.79M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $43.36M 10-Q · filed 2026-02-05 | |
| 2025-09-30 | $43.89M 10-Q · filed 2026-08-04 | |
| 2025-06-30 | $44.00M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $44.45M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $44.87M 10-Q · filed 2025-02-10 | |
| 2024-09-30 | $45.26M 10-K · filed 2025-11-25 | |
| 2024-06-30 | $44.34M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $44.63M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $44.91M 10-Q · filed 2024-02-06 | |
| 2023-09-30 | $45.30M 10-K · filed 2024-11-26 | |
| 2023-06-30 | $40.67M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $41.11M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $41.66M 10-Q · filed 2023-02-06 | |
| 2022-09-30 | $58.29M 10-K · filed 2023-11-29 | |
| 2022-06-30 | $68.91M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $16.38M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $16.88M 10-Q · filed 2022-02-02 | |
| 2021-09-30 | $17.35M 10-K · filed 2022-11-28 | |
| 2021-06-30 | $18.45M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $18.37M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $15.75M 10-Q · filed 2021-02-04 | |
| 2020-09-30 | $16.14M 10-K · filed 2021-11-22 | $16.14M 10-K · filed 2020-11-23 |
| 2020-06-30 | $16.52M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $10.26M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $10.44M 10-Q · filed 2020-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |